+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of Chlamydia pneumoniae

Treatment of Chlamydia pneumoniae

International Journal of Antimicrobial Agents 15(3): 239, 241-239, 241

(PDF same-day service: $19.90)

Accession: 035980367

Download citation: RISBibTeXText

PMID: 10926449

DOI: 10.1016/s0924-8579(00)00164-3

Related references

Prevalence of chlamydia pneumoniae in Japanese rural districts; association of smoking and physical activity with Chlamydia pneumoniae seropositivity. Internal Medicine 42(10): 960-966, 2003

Multiplex polymerase chain reaction for the simultaneous detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Chlamydia psittaci in respiratory samples. Journal of Clinical Pathology 52(4): 257-263, 1999

Foam cell formation inhibits replication of Chlamydia pneumoniae but does not attenuate Chlamydia pneumoniae induced secretion of pro-inflammatory cytokines. Circulation 102(18 Supplement): II 54, October 31, 2000

Foam cell formation inhibits growth of Chlamydia pneumoniae but does not attenuate Chlamydia pneumoniae-induced secretion of proinflammatory cytokines. Circulation 105(16): 1976-1982, 2002

Low prevalence of Chlamydia pneumoniae, Chlamydia trachomatis and Mycoplasma pneumoniae in young children hospitalized with lower respiratory tract infections. European Respiratory Journal 8(SUPPL 19): 116S, 1995

Pneumonia and bronchitis with Chlamydia pneumoniae and Mycoplasma pneumoniae Disease incidence and treatment with azithromycin. Abstracts of the General Meeting of the American Society for Microbiology 93(0): 9, 1993

Prevalence of Chlamydia pneumoniae in acute respiratory tract infection and detection of anti-Chlamydia pneumoniae-specific IgE in Japanese children with reactive airway disease. Kurume Medical Journal 48(2): 165-170, 2001

Method of detecting anti-Chlamydia pneumoniae antibody using Chlamydia pneumoniae-specific antigens. Official Gazette of the United States Patent & Trademark Office Patents 1265(1), Dec 3, 2002

Simultaneous detection of Chlamydia pneumoniae and Chlamydia trachomatis DNA by real-time PCR FT Soucasny prukaz DNA Chlamydia pneumoniae a Chlamydia trachomatis pomoci real-time PCR. 2007

Antibodies to Chlamydia species in patients attending a genitourinary clinic and the impact of antibodies to Chlamydia pneumoniae and Chlamydia psittaci on the sensitivity and the specificity of Chlamydia trachomatis serology tests. Sexually Transmitted Diseases 20(2): 61-65, 1993

Limites et perspectives du diagnostic serologique a l'ere de l'amplification genique in vitro: infections genitales a Chlamydia trachomatis et infections respiratoires a Chlamydia pneumoniae et Mycoplasmal pneumoniae. Annales de Biologie Clinique 64(5): 409-419, 2006

Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis. Experimental & Molecular Medicine 34(6): 391-400, 2003

Prevalence of Chlamydia trachomatis, Chlamydia psittaci and Chlamydia pneumoniae antibodies in blood donors and attendees of STD clinics. Clinical Microbiology and Infection 1(4): 253-260, 1996

Differences in the envelope proteins of Chlamydia pneumoniae, Chlamydia trachomatis, and Chlamydia psittaci shown by two-dimensional gel electrophoresis. Archives of Microbiology 165(3): 164-168, 1996

Evaluation of a new commercial microimmunofluorescence test for detection of antibodies to Chlamydia pneumoniae, Chlamydia trachomatis, and Chlamydia psittaci. European Journal of Clinical Microbiology & Infectious Diseases 16(9): 685-688, 1997